Showing posts with label HealthCare. Show all posts
Showing posts with label HealthCare. Show all posts

Friday 2 August 2019

Cancer Biological Therapy Market Share, Growth Factors, Historical Analysis, Sales Revenue, Development Status, Emerging Opportunities, Competitive Landscape and Regional Forecast to 2023

Market Highlights
Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.


Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Segmentation:
The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Regional Analysis:
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Global Cancer Biological Therapy Market Players:
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis,Pfizer Inc. and others.


Latest Trending Reports 

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Wednesday 31 July 2019

Healthcare Biometrics Market Sees Promising Growth by 2023 According to New Research Report

Healthcare Biometrics Market Research Report - Global Forecast to 2022
Market Research Future recently presented Global Healthcare Biometrics Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2022.
Biometrics after garnering huge prominence in banking, insurance, and public security sector, are all set to revalorize healthcare sector. Healthcare (HC) officials can leverage some unique approaches using the biometrics techniques such as facial recognition solutions, fingerprint scanners, palm vein readers, and iris scanners among others, in combination with their smartphones.
Implementing these emerging technologies makes it easier for hospitals, practices, payers and other healthcare organizations to recognize individual patients and match an individual's medical data which holds considerable promise. As a result, healthcare biometrics (HB) market is growing pervasively and rapidly.
Recognizing the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global healthcare biometrics market is expected to evaluate at USD 5.6 BN by 2022, registering a whopping CAGR of 22.3% during the forecast period (2016 – 2022).
Factors such as spreading awareness about HB technologies and their increasing applications across the healthcare sector along with the proliferating HC insurance market is driving the market of biometrics in healthcare.
Additional factors substantiating the market growth include the growing population, and extensive penetration of healthcare facilities, worldwide. Rapidly improving economic conditions are positively impacting the market growth, availing quality care and insurance facilities, across the globe.
Although biometric technologies have long held promise leveraging, identification of patients and employees, these have been slow to catch on in healthcare. Surely, many hospitals and clinics have implemented some technologies; however, biometrics is not yet entirely in the mainstream of healthcare practices. These factors might obstruct the market growth.
Patient identification and matching is an ongoing healthcare problem worldwide, and, especially in developed regions where the law prohibits the standard identifier, it is made even more complicated, and interoperability and record matching issues are still intimidating HC officials to varying extents. However, with time and seminal efforts put in by healthcare CISOs and biometrics technology vendors, HB is soon expected to get in the mainstream.
Key Players
Some of the eminent leaders of the market include 3M Cogent Inc., Fujitsu Limited, BioEnable Technologies, Morpho (A Subsidiary of Safran SA), NEC Corporation, Bio-Key International, Inc., Crossmatch Technologies Inc., Suprema, Inc., Integrated Biometrics, and Imprivata Inc.
Global Healthcare Biometrics Market   - Segments
MRFR has segmented its analysis into four key dynamics for enhanced understanding.
By Technologies    : Face Recognition, Fingerprint Recognition, Vein Recognition, Behavioral Recognition, Iris Recognition, and Palm Geometry Recognition among others.
By Applications     : Patient Identification, Patient Monitoring, Medical Record Management, Data Security, and others.
By End-users           : Hospitals, Research Laboratories, and Healthcare Institutes among others.
By Regions              :  Europe, North America, APAC and the Rest-of-the-World.
Global Healthcare Biometrics Market – Geographical Analysis
Globally the North American region accounts for the largest market for healthcare biometrics mainly due to the well-established healthcare sector and the augmenting demand for regulatory requests. Simultaneously, some factors such as increasing digital advancements in medical technology, extensive uptake of healthcare biometrics in hospitals, along with the presence of the proliferating healthcare insurance industry are propelling the market growth in the region.
Also, demand for user-friendly software along with the importance of electronic medical records contributes to the market growth. The US backed with the developments in authentication solutions, patient identification, medical record management, patient monitoring, and data security, majorly supports the market growth in the region.
The European region is another lucrative market for healthcare biometrics standing at the second position. The market is heading with the augmenting demand for HB across the region. Undoubtedly, the resurging economy in the region is a dominant factor substantiating the market growth, increasing healthcare facilities.  Also, the increased funding in the rising numbers of the medical record management concerns, especially in the field of Insurance are providing impetus to the market growth in the region.
The healthcare biometrics market in the Asia Pacific region is rapidly emerging as a promising market.  Burgeoning healthcare sector along with the rapidly developing biometric models and technologies defines the market landscape in the region. Furthermore, rapidly improving economic conditions along with the market penetration of healthcare technology in the region provide impetus to the market growth. The healthcare biometrics market in the APAC with some of its untapped regions offers high growth opportunities.
Global Healthcare Biometrics Market   - Competitive Landscape
Highly competitive Healthcare Biometrics market appears to be fragmented owing to the presence of several big & small market players along with new entrants churning the competition. Key players are adopting the strategic trends for business expansion in the emerging markets. Key market players are focusing on optimized situational awareness for customers, ensuring their mission success. Matured players, through various strategies such as collaboration, M&A activities, and innovations are continually seeking market expansion.
They increasingly invest in R&D activities and to develop cost-effective product portfolio. These players possess state of the art facilities to develop software and strong sales and distribution network which have helped them to gain the leadership position in the market. Marketers operating in the Clinical Practice Management industry are focusing on inbound lead generation more than ever.  Industry’s marketing executives look for ROI-oriented strategies that can pay off quickly.
Table of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Healthcare Biometrics Market by Technology
...

Healthcare Trending Reports
About Us
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: , , ,

Monday 29 July 2019

Intelligent Pills Market Booming With Highest CAGR By 2023

Intelligent Pills Market – Overview
Intelligent Pills/ Smart Pills further to its invention in 2012 have evolved with technology in the pharmaceutical field solving problems that have overwhelmed the healthcare industry for decades and improving overall therapeutic effectiveness. Tiny ingestible sensors in Intelligent Pills using Bluetooth, established communication with an adhesive pad patients wearing on their chests  the real-time data is then shared on associated Smartphone app that passes the readings to doctors, family members and caretakers alike. This ultimately helps in dealing with the medication adherence issues that further lead to many health problems worldwide, that restricting the therapeutic effectiveness of medicines which account for a substantial amount of money causing unnecessarily increasing span of treatment. Due to this tremendous efficacy Intelligent Pills are increasingly gaining popularity consecutively its market value is ascending pervasively on the global platform further opening galore opportunities for the healthcare sector to evolve and grow.
Accrediting the sedulous work of the key players & researchers, bringing novelties in Intelligent Pills and helping its market to gain increasing traction and grow widely, the Market Research Future has recently published a meticulous study report, giving out the complete market prognosis up to 2027. According to which, the Global Intelligent Pills Market is expected to grow further continuing with the same trend over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value.
Factors that predominantly drive the Intelligent Pills market growth include rising awareness about Intelligent Pills among the patients and doctors alike. Additionally, Presence of large number of geriatric population that needs timely medication but tend to forget at times is anticipated to fuel the market growth of Intelligent Pills. Schizophrenia patients & patients with mental disorders, who are incapable to keep a log of their medications or tend to be reckless towards or sometimes even deny medications completely, this worsens the scenario. Such patients actually need intensive care & regularities of medication and their caregivers are overwhelmed by trying to manage the gamut and desperately wish for having some alternative method and assistance for recording the readings. In such cases Intelligent Pills are reliably helping their care givers & family members to keep a tab on patients’ medications. Therefore, increasing number of Schizophrenia patients & patients with mental disorders is expected to provide extensive impetus to the Intelligent Pills market growth owing to the reliable assistance it provides.
On other hand lack of awareness towards befits of Intelligent Pills coupled with the scepticism of physicians are posing challenges to the Intelligent Pills market growth. The high manufacturing cost and complexity of production, along with the unclear regulatory policies in many countries are expected to pose as major constraints for the global Intelligent Pills market during the forecast period. Alternatively, technological advancements coupled with growing number of pharma companies that can manufacture Intelligent Pills on a high production rate is expected to bring the production cost down, this factor is expected to escalate the Intelligent Pills market growth to the next level during the forecasted period.
Key Players for Intelligent Pills Market:
Some of the key players in this market are:
  • CapsoVision, Inc. (US)
  • Given Imaging Ltd. (Israle)
  • Medimetrics (Mexico)
  • (Bio-Images Drug Delivery) BDD LTD (UK)
  • Proteus Digital Health (US)
Intelligent Pills Global Market – Competitive Analysis
The Global Intelligent Pills Market is driven by some of the prominent players including CapsoVision, Inc. (US), Given Imaging Ltd. (Israle), Medimetrics (Mexico), (Bio-Images Drug Delivery) BDD LTD (UK), and Proteus Digital Health (US) among others. Acknowledging, the sedulous work of these key players, MRFR profiles them in its market analysis.
The global market of Intelligent Pills appears to be moderately competitive and consolidated with the limited number of key players operating in the market with the presence of several well-established and small players. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market. Top players are investing heavily in R&D and clinical trials to develop effective Intelligent Pills.
Industry/Innovation/ Related News:
November 14, 2017 - The Food and Drug Administration approved the Intelligent Pill called Ability, or medication with a sensor. Japanese drug maker Otsuka Pharmaceutical won the approval for ‘ Ability’, prescribed to adults for bipolar disorder, schizophrenia mania and some forms of depression.
September 12, 2017 -   Researchers at Caltech (US) presented their study foe the prototype miniature medical device that they have developed which could ultimately be used in "smart pills" to diagnose and treat diseases. A key to the new technology—and what makes it unique among other microscale medical devices is that its location can be precisely identified within the body, something that proved challenging before.
February 17, 2017 - Eindhoven University of Technology (South Netherlands) Researchers presented a new method that should enable controlled drug delivery into the bloodstream using DNA computers. The team developed the first DNA computer capable of detecting several antibodies in the blood and performing subsequent calculations based on this input. This is an important step towards the development of smart, 'intelligent' drugs that may allow better control of medication with fewer side-effects and at lower cost.
Intelligent Pills Global Market – Segmentation
The Intelligent Pills Market is segmented in to 3 key dynamics for the convenience of the report and enhanced understanding;
Segmentation ByApplication         : Comprises Sleeping disorders, capsule endoscopy, Reflux Monitoring, Mobility Monitoring, Stress Management, and others.
Segmentation By Prescription       : Comprises Prescription Smart Drugs and others.
Segmentation ByRegions              : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Thursday 18 July 2019

Cancer Diagnostics Market Anticipated to Grow at a Significant Pace by 2023

Global Cancer Diagnostics Market: Synopsis
The detailed report that has been recently published by Market Research Future (MRFR) projects that the global cancer diagnostics market is marked to exhibit noteworthy expansion at a CAGR of 11.85% during the forecast period of 2017-2023. Rise in prevalence of individuals suffering from cancer and high demand for advanced diagnostic procedures in order to receive precise and effective treatment are majorly propelling the growth of the global cancer diagnostic market. Increasing availability of diagnosis solution in the healthcare sector in the developed and developing regions and rise in government initiatives to spread awareness in the underdeveloped regions are also fueling the growth of the global cancer diagnostics market.


Global Cancer Diagnostics Market: Key Players
The prime players profiled by MRFR that are operating in the global cancer diagnostics market are Armune BioScience, Inc. (the U.S.), Arquer Diagnostics Ltd (the U.K), BioMark Diagnostics Inc. (Canada), Biotheranostics, Inc. (the U.S.), Cancer Diagnostics, Inc. (the U.S.), Agilent Technologies, Inc. (the U.S.), Thermo Fisher Scientific, Inc. (the U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (the U.S.), GE Healthcare (the U.K), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (the U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (the U.K.), and C.R. Bard, Inc. (the U.S.).

Global Cancer Diagnostics Market: Segmental Analysis
The global cancer diagnostics market has been segmented on the basis of types, application, and end user. Based on type, the global cancer diagnostics market has been segmented into biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics, and others. Based on application, the global cancer diagnostics market has been segmented into lung cancer, breast cancer, colorectal cancer, cervical cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, and others. Based on end user, the global cancer diagnostics market has been segmented into diagnostic center, clinic, hospital, research institutes, and others.

Global Cancer Diagnostics Market: Regional Analysis
Geographically, the global cancer diagnostics market ha been segmented into four major regions such as the Americas, Asia Pacific, Europe and the Middle East and Africa. The Americas command the major share of the global cancer diagnostics market owing to the high prevalence of individuals suffering from cancer, rapid adoption of advanced technology in order to improve the diagnostics and treatment solutions in the well-developed healthcare infrastructure and increased expenditure on healthcare by the population in this region. Technological advancement is aiding the pharmaceutical industry to carry out extensive research activities for the development of advanced diagnostics procedure in order to provide accurate treatment for curing cancer, which in turn is propelling the growth of the cancer diagnostics market in the Europe region. Increasing awareness regarding the availability of advanced diagnostics procedures in the healthcare sector of emerging economies, rise in prevalence of cancer, and increased government initiatives to support cancer patients to get thorough diagnosis and effective treatments with the help of favorable reimbursement policies are fueling the expansion of the cancer diagnostics market in the Asia Pacific region. Lack of awareness and low penetration of advanced diagnostics solution in the remote areas of the underdeveloped countries are leading to the steady growth of the cancer diagnostics market in the Middle East and Africa market.

Global Cancer Diagnostics Market: Industry Updates
In january 2019, MRM Proteomics inc. has partnered with biodesix which will allow Biodesix to utilize MRM Proteomics's proprietary iMALDI technologies to improve the blood-based lung cancer diagnostics.
In January 2019, Veracyte, a U.S.-based genomic diagnostics comapny has partnered with Johnson & Johnson Innovation for the development and commercialization of new tests for detection of lung cancer during the early stages.
In January 2019, ArcherDx, The Boulder CO-based company has announced that it has been granted with Breakthrough Device Designation for its tissue specimen diagnostic and liquid biopsy application for effective cancer diagnostic.

Intended Audience
  • Cancer specific medical device manufacturers
  • Cancer specific medical device suppliers
  • Government Research Laboratory
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
Hottest Trending Reports

 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , , ,

Wednesday 10 July 2019

Wearable Medical Device Market Expected to Witness a CAGR of 46.6% over 2022

Market Scenario
Market Research Future (MRFR) proclaims that the global wearable sensors market is estimated to register a striking CAGR of 46.6% during the forecast period (2018-2023). The continuously evolving sensor technology is favoring the market growth. The wearable sensor is referred to as a technological device which is worn by the individuals to track information associated with fitness and health. Such sensors are integrated into several accessories like hats, wristwatches, smartphones, eyeglasses, garments, shoes, wrist bands, headphones, and others which monitors and diagnose vital signs like blood pressure, heart rate, and other metabolic activities. These sensors enable biological and physiological sensing.


Market Potential and Pitfalls
The wearable sensors market is rapidly stealing the spotlight with increased consciousness regarding health and personal care. The demand for wearable fitness tracker is continuously on the rise to track biometrics like heart rate, calories burnt, and others. Internet of Things has mushroomed in the recent past which is triggering the demand for wearable sensors devices in application areas like consumer electronics, fitness and healthcare, and others. Wearable sensors enable continuous monitoring which has encouraged the behavior pattern of the buyers. There is a noticeable shift towards healthy lifestyle which has influenced people to adopt wearable sensors.
With the advancement in sensor technology, power supply technology, wireless communication devices/technology, and others, the wearable sensors market is receiving the pat. Boltt launched an AI-enabled wearable device in 2017 which constituted of smart shoes to sensors for health and fitness solutions. Factors such as advancements in sensor technology, surging adoption of remote and home patient monitoring, and increased use of wearable devices for infants have enabled the market to reach out to a wider range of audiences. The use of smart consumer electronic devices like smartphones and tablets have enabled the gathering and monitoring of data as these wearable sensors can be paired with other devices. The advent of new devices like the smart ring, smart shirt, eyewear, and others have further amplified the demand for wearable devices worldwide. With pressure sensors extremely becoming popular due to its miniaturization factor, the market is gaining impetus. Sensing muscle activity enables a sportsperson to train specific muscles and gain feedback regarding their performance quality. With pressure sensing shoes being used in motion capture technologies, the era of computer animation has transformed during the past decade.
On the contrary, the concerns associated with privacy, the high cost of the wearable sensors, and data integrity are some of the top barriers considered to vitiate the market growth in the coming years. On a brighter note, strict mandates related to data storage is likely to augment the popularity of wearable devices in the long run.
Global Wearable Sensors Market: Segmental Analysis
The global wearable sensors market has been segmented on the basis of type, application, and end-users.
By mode of type, the global wearable sensors market has been segmented into medical based sensors, motion sensors, position sensors, image sensors, inertial sensors, pressure sensors, and others.
By mode of application, the global wearable sensors market has been segmented into smart glasses, smart wristwear, smart footwear, smart body wears, and others. Among these, the smart wristwear segment occupied the major share across the globe. The growth is ascribed to the increased popularity of fitness and health devices among the consumers. New entrants are offering advanced technologies in smart wristwear at lower prices than smartwatches, which is likely to encourage the growth of the segment. These wristwear offer dynamic analysis of the user activities like heart rate variation, step tracking, sleep quality analysis, and calories count which further add to its functionality.
By mode of end-users, the global wearable sensors market has been segmented into healthcare, consumer, industrial and enterprise, and others. Among these, the consumer segment is likely to gain prominence. The demand for sensor-fused devices are triggering with the increased awareness regarding remote monitoring of fitness and wellness is gaining prominence among the users.
Regional Insights
Geographically, the wearable sensors market span across regions namely, Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).
Considering the global scenario, the North American region is poised to occupy the most significant share as the region offer room to the most prominent players and is in a position to adopt technological advancements at its earliest. High adoption of digital technology in the U.S. has further intensified the growth of the market in this region. With the booming healthcare infrastructure, the market is estimated to flourish.
The European region occupies the second spot and is anticipated to evolve at a significant pace in the foreseeable future. With advancing technology and purchasing power required for the market growth, the region is anticipated to gain an impetus. Moreover, the conscious awakening regarding healthy lifestyle is considered a major factor propelling the market growth in the long run.
The Asia Pacific region is estimated to expand at the fastest rate as the strong economic growth has infused healthy purchasing power which is estimated to encourage the proliferation of wearable sensors in the coming years.
Industry Updates
April 02, 2019: A team of researchers at the Binghamton University, State University of New York have recently developed skin-inspired electronics to conform to the skin, which allows high-performance, long-term, and real-time wound monitoring in the users.
Competitive Dashboard
The prominent players operating in the global wearable sensors market comprises Freescale Semiconductor Inc., KIONIX INC. (ROHM Co., Ltd.), InvenSense Inc., Panasonic Corporation, Analog Devices Inc., STMicroelectronics, ZOLL Medical Corporation (Asahi Kasei Corporation), InvenSense Inc., Measurement Specialties Inc., Robert Bosch GmbH, Infineon Technologies AG., and Texas Instruments Incorporated.
Table Of Content
1. Report Prologue
2. Market Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Global Wearable Sensors Market, By Deployment
7. Global Wearable Sensors Market, By Application
8. Global Wearable Sensors Market, By End User
……
List Of Tables:
TABLE 1 Specific Primary And Secondary Sources Used For This Publication 14 
TABLE 2 Global Wearable Sensors Market Snapshot(2015and 2020) 16 
TABLE 3 Drivers For The Market: Impact Analysis 29 
TABLE 4 Restraints For The Market: Impact Analysis 32 
TABLE 5 Global Market Breakdown By Type, $M (2012 – 2014) 36 
TABLE 6 Global Market Breakdown By Type, Million Units (2012 – 2014) 37 
TABLE 7 Global Market Breakdown By Type, $M (2015 – 2020) 37 
TABLE 8 Global Market Breakdown By Type, Million Units (2015 – 2020) 38 
TABLE 9 Global Market Breakdown By Application, $M (2012 – 2014) 39 
TABLE 10 Global Market Breakdown By Application, Million Units (2012 – 2014) 40 
TABLE 11 Global Market Breakdown By Application, $M (2015 – 2020) 40 
TABLE 12 Global Market Breakdown By Application, Million Units (2015 – 2020) 40 
TABLE 13 Global Market Breakdown By End User, $M (2012 – 2014) 41 

Read More @ https://www.marketresearchfuture.com/reports/wearable-sensors-market-955

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , , ,

Tuesday 9 July 2019

Cancer Biological Therapy Market: Analysis Regions (North America, Europe, Middle East, ROA, Africa) 2018-2023

Cancer Biological Therapy Market Highlights
Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.
Get Latest Sample PDF Of Cancer Biological Therapy Market Report @ https://www.marketresearchfuture.com/sample_request/566
Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Cancer Biological Therapy Market Segmentation:
The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Cancer Biological Therapy Market Regional Analysis:
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Global Cancer Biological Therapy Market Players:
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis,Pfizer Inc. and others.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Pricing Analysis
Chapter 6. Global Cancer Biological Therapy Market, By Type
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email:  sales@marketresearchfuture.com

Posted by at No comments:
Labels: , ,

Friday 5 July 2019

Opioids Market 2019 Trends, Industry Size, Segmentation, Sales Revenue, Growth Factors, Key Players Update, Demand Comprehensive Research Study Till 2023 - Market Research Future

Market Highlights
The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.
The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years. However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.
Segment analysis
The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Regional Analysis
The Americas is expected to hold the largest share of the global opioids market. This is owing to rising intravenous usage of opioids in the region. Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.
Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids. Asia-Pacific is estimated to be the fastest growing region in the global market. Populace demographics and increased availability of effective opioid medications are likely to be the key factors for the growth of Asia-Pacific opioids market during the forecast period. South Korea held a share of 6% in the Asia-Pacific opioids market in 2017. Also, the Middle East and Africa region is expected to steadily grow owing to the rising number of opioid manufacturers in the North African region.
Key Findings of the Study
  • The global opioids market is projected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% during the review period from 2018 to 2023
  • Americas accounted for the largest share of the global market due to rising intravenous drug use in the region.
  • The extended-release opioid segment accounted for the largest product segment revenue of USD 12,750.91 million in 2017.
  • Some of the players operating in the opioids market are Egalet Corporation, Purdue Pharma L.P., and Vertice Pharma, among others.
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Related Reports
  • Medical Morphine Market Information: By Route of Administration (Oral, Injectable) Application (Arthritis, Cancer, Kidney Stones,) Distribution Channel (Hospital Pharmacy, Online Pharmacy), and End-User (Hospitals & Clinics )– Global Forecast Till 2023
  • Global Medical Marijuana Market: Information by Application (Cancer, Multiple Sclerosis, Alzheimer’s, and Muscle Spasms), Route of Administration (Oral, Topical, and Others), Distribution Channel (Dispensaries and Others) – Global Forecast Till 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Anticholinergic Drugss Market 2019: Increasingly connected Home healthcare applications

Market Highlights
The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% during the forecast period with a market value of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.
The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.
Segment Analysis
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.
Market Players
Market Research Future (MRFR) recognizes following companies as key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany) and others.
Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Key Findings of the Study
  • The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50%during the review period from 2019 to 2024.
  • Americas accounted for the largest share of the global market due to the high prevalence of CNS diseases and demand for effective therapies.
  • The overactive bladder application segment accounted for the largest market share of 4% in 2018.
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Tumor ablation Market Industry Status, Key Regions, Application, Top Key Players, Future and Forecast Till 2023

Market Highlights:Tumor ablation is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the tumor ablation market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing research and development in healthcare and advancement in technologies. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities.
The cost containment policies by various governments, stringent regulatory environment for product approval, and scarcity of experts are likely to hinder market growth during the forecast period. 
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/7139
Regional Analysis:The American market is expected to dominate the global tumor ablation market during the forecast period due to the increase in number of cancer cases along with growing geriatric population, adoption of advance technology in healthcare, and favorable reimbursement and regulatory authorities. The European market is expected to be the second-largest due to increased pool of cancer patients and rising healthcare expenditure.Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population in countries such as India and China, government initiatives and investment for the development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global tumor ablation market.
Segmentation:The Global Tumor Ablation Market has been segmented on the basis of technology, treatment, application, and end-user.
The technology segment has been segregated into Radiofrequency, Microwave, Irreversible Electroporation, Cryoablation and others.
On the basis of treatment, the market has been classified as surgical, percutaneous and laparoscopic.
The tumor ablation market, by application, has been segmented into Liver cancer, Lung cancer, Breast cancer, Bone cancer, Prostate cancer and others.
End-user segment is divided into hospitals, surgical and ablation centers, and research institute.
Key Players:Some of the key players in the global tumor ablation market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Biotronik, Galil Medical, Inc, Misonix Inc., and Covidien PL

Browse Complete Report @ https://www.marketresearchfuture.com/reports/tumor-ablation-market-7139
About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , , , ,

Tuesday 2 July 2019

Healthcare Biometrics Market Demand is Increasing Rapidly in Recent Years!!

Biometrics after garnering huge prominence in banking, insurance, and public security sector, are all set to revalorize healthcare sector. Healthcare (HC) officials can leverage some unique approaches using the biometrics techniques such as facial recognition solutions, fingerprint scanners, palm vein readers, and iris scanners among others, in combination with their smartphones.
Implementing these emerging technologies makes it easier for hospitals, practices, payers and other healthcare organizations to recognize individual patients and match an individual's medical data which holds considerable promise. As a result, healthcare biometrics (HB) market is growing pervasively and rapidly.
Recognizing the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global healthcare biometrics market is expected to evaluate at USD 5.6 BN by 2022, registering a whopping CAGR of 22.3% during the forecast period (2016 – 2022). 
Factors such as spreading awareness about HB technologies and their increasing applications across the healthcare sector along with the proliferating HC insurance market is driving the market of biometrics in healthcare.
Additional factors substantiating the market growth include the growing population, and extensive penetration of healthcare facilities, worldwide. Rapidly improving economic conditions are positively impacting the market growth, availing quality care and insurance facilities, across the globe.
Although biometric technologies have long held promise leveraging, identification of patients and employees, these have been slow to catch on in healthcare. Surely, many hospitals and clinics have implemented some technologies; however, biometrics is not yet entirely in the mainstream of healthcare practices. These factors might obstruct the market growth. 
Patient identification and matching is an ongoing healthcare problem worldwide, and, especially in developed regions where the law prohibits the standard identifier, it is made even more complicated, and interoperability and record matching issues are still intimidating HC officials to varying extents. However, with time and seminal efforts put in by healthcare CISOs and biometrics technology vendors, HB is soon expected to get in the mainstream.
Global Healthcare Biometrics Market – Geographical Analysis
Globally the North American region accounts for the largest market for healthcare biometrics mainly due to the well-established healthcare sector and the augmenting demand for regulatory requests. Simultaneously, some factors such as increasing digital advancements in medical technology, extensive uptake of healthcare biometrics in hospitals, along with the presence of the proliferating healthcare insurance industry are propelling the market growth in the region. 
Also, demand for user-friendly software along with the importance of electronic medical records contributes to the market growth. The US backed with the developments in authentication solutions, patient identification, medical record management, patient monitoring, and data security, majorly supports the market growth in the region.
The European region is another lucrative market for healthcare biometrics standing at the second position. The market is heading with the augmenting demand for HB across the region. Undoubtedly, the resurging economy in the region is a dominant factor substantiating the market growth, increasing healthcare facilities.  Also, the increased funding in the rising numbers of the medical record management concerns, especially in the field of Insurance are providing impetus to the market growth in the region.
The healthcare biometrics market in the Asia Pacific region is rapidly emerging as a promising market.  Burgeoning healthcare sector along with the rapidly developing biometric models and technologies defines the market landscape in the region. Furthermore, rapidly improving economic conditions along with the market penetration of healthcare technology in the region provide impetus to the market growth. The healthcare biometrics market in the APAC with some of its untapped regions offers high growth opportunities.
Global Healthcare Biometrics Market   - Segments
MRFR has segmented its analysis into four key dynamics for enhanced understanding.
By Technologies    : Face Recognition, Fingerprint Recognition, Vein Recognition, Behavioral Recognition, Iris Recognition, and Palm Geometry Recognition among others.
By Applications     : Patient Identification, Patient Monitoring, Medical Record Management, Data Security, and others.
By End-users           : Hospitals, Research Laboratories, and Healthcare Institutes among others.
By Regions              :  Europe, North America, APAC and the Rest-of-the-World.
Global Healthcare Biometrics Market   - Competitive Landscape
Highly competitive Healthcare Biometrics market appears to be fragmented owing to the presence of several big & small market players along with new entrants churning the competition. Key players are adopting the strategic trends for business expansion in the emerging markets. Key market players are focusing on optimized situational awareness for customers, ensuring their mission success. Matured players, through various strategies such as collaboration, M&A activities, and innovations are continually seeking market expansion.
They increasingly invest in R&D activities and to develop cost-effective product portfolio. These players possess state of the art facilities to develop software and strong sales and distribution network which have helped them to gain the leadership position in the market. Marketers operating in the Clinical Practice Management industry are focusing on inbound lead generation more than ever.  Industry’s marketing executives look for ROI-oriented strategies that can pay off quickly.
Key Players:
Some of the eminent leaders of the market include 3M Cogent Inc., Fujitsu Limited, BioEnable Technologies, Morpho (A Subsidiary of Safran SA), NEC Corporation, Bio-Key International, Inc., Crossmatch Technologies Inc., Suprema, Inc., Integrated Biometrics, and Imprivata Inc.
Industry/ Innovation /Related News:
October 10, 2018 – Ipsidy Inc. (US), a leading global provider of trusted transactions with identity at the core & enhances security with biometric identity & multi-factor authentication mobile solutions announced a partnership with Safetrade Africa to extend its distribution reach in the African market.  Safetrade will act as a reseller in southern African countries and the Indian Ocean islands of Madagascar, Mauritius, and Seychelles.
August 13, 2018 – Ipsidy Inc. (US) announced the launch of Access™ Mobile Biometric Perimeter Protection Access is a mobile, biometric identity access management solution that helps in protecting any perimeter & create a safe environment, monitoring the identities of enrolled people moving in and out around any defined area.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Pricing Analysis
Chapter 6. Global Healthcare Biometrics Market, By Type
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)